Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Multiple Sclerosis

  Free Subscription


1 AJNR Am J Neuroradiol
1 Ann Neurol
1 Arch Phys Med Rehabil
1 Curr Treat Options Neurol
1 J Immunol
4 J Neurol
3 J Neurol Sci
2 Mult Scler
2 PLoS One
1 Rev Neurol (Paris)

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    AJNR Am J Neuroradiol

  1. MCNAMARA C, Sugrue G, Murray B, MacMahon PJ, et al
    Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.
    AJNR Am J Neuroradiol. 2017 Apr 20. doi: 10.3174/ajnr.A5148.
    PubMed     Text format     Abstract available

    Ann Neurol

  2. SELMAJ I, Cichalewska M, Namiecinska M, Galazka G, et al
    Global Exosome Transcriptome Profiling Reveals Biomarkers for Multiple Sclerosis.
    Ann Neurol. 2017 Apr 15. doi: 10.1002/ana.24931.
    PubMed     Text format     Abstract available

    Arch Phys Med Rehabil

  3. BOUCHARD V, Duquette P, Mayo NE
    Path to Illness Intrusiveness: What Symptoms Impact the Life of People Living with Multiple Sclerosis?
    Arch Phys Med Rehabil. 2017 Apr 15. pii: S0003-9993(17)30236.
    PubMed     Text format     Abstract available

    Curr Treat Options Neurol

  4. SUTHIPHOSUWAN S, Kim D, Bharatha A, Oh J, et al
    Imaging Markers for Monitoring Disease Activity in Multiple Sclerosis.
    Curr Treat Options Neurol. 2017;19:18.
    PubMed     Text format     Abstract available

    J Immunol

  5. HOHLFELD R, Steinman L
    T Cell-Transfer Experimental Autoimmune Encephalomyelitis: Pillar of Multiple Sclerosis and Autoimmunity.
    J Immunol. 2017;198:3381-3383.
    PubMed     Text format    

    J Neurol

  6. MAILLART E, Papeix C, Mellerio C, Bertrand A, et al
    Extensive and severe CNS demyelination associated with golimumab therapy.
    J Neurol. 2016;263:1869-71.
    PubMed     Text format    

  7. KHAN F, Amatya B, Galea MP, Gonzenbach R, et al
    Neurorehabilitation: applied neuroplasticity.
    J Neurol. 2017;264:603-615.
    PubMed     Text format     Abstract available

  8. SARTORI A, Abdoli M, Freedman MS
    Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.
    J Neurol. 2017 Apr 17. doi: 10.1007/s00415-017-8487.
    PubMed     Text format     Abstract available

  9. HARDING K, Tilling K, MacIver C, Willis M, et al
    Seasonal variation in multiple sclerosis relapse.
    J Neurol. 2017 Apr 19. doi: 10.1007/s00415-017-8485.
    PubMed     Text format     Abstract available

    J Neurol Sci

  10. BRAMBILLA L, Rossi Sebastiano D, Aquino D, Torri Clerici V, et al
    Early effect of dalfampridine in patients with MS: A multi-instrumental approach to better investigate responsiveness.
    J Neurol Sci. 2016;368:402-7.
    PubMed     Text format     Abstract available

  11. MESSMER UCCELLI M, Traversa S, Ponzio M
    A survey study comparing young adults with MS and healthy controls on self-esteem, self-efficacy, mood and quality of life.
    J Neurol Sci. 2016;368:369-73.
    PubMed     Text format     Abstract available

  12. SACCA F, Pane C, Carotenuto A, Massarelli M, et al
    The use of medical-grade cannabis in patients non-responders to Nabiximols.
    J Neurol Sci. 2016;368:349-51.
    PubMed     Text format    

    Mult Scler

  13. KOLBER P, Droby A, Roebroeck A, Goebel R, et al
    A "kissing lesion": In-vivo 7T evidence of meningeal inflammation in early multiple sclerosis.
    Mult Scler. 2017 Apr 1:1352458516683267. doi: 10.1177/1352458516683267.
    PubMed     Text format     Abstract available

  14. KILSDONK ID, Schoonheim M, Wattjes MP
    In-vivo imaging of meningeal inflammation in multiple sclerosis: Presence of evidence or evidence of presence?
    Mult Scler. 2017 Apr 1:1352458517704924. doi: 10.1177/1352458517704924.
    PubMed     Text format    

    PLoS One

  15. SHARMA S, Zhang Y
    Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    PLoS One. 2017;12:e0175979.
    PubMed     Text format     Abstract available

  16. NAVAS-MADRONAL M, Valero-Mut A, Martinez-Zapata MJ, Simon-Talero MJ, et al
    Absence of antibodies against KIR4.1 in multiple sclerosis: A three-technique approach and systematic review.
    PLoS One. 2017;12:e0175538.
    PubMed     Text format     Abstract available

    Rev Neurol (Paris)

  17. DE SEZE J, Kremer L, Collongues N
    Neuromyelitis optica spectrum disorder (NMOSD): A new concept.
    Rev Neurol (Paris). 2016;172.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.